Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1552-1558

  Lundeen, Scott G ^a   Carver, Jeffrey M ^a   McKean, Mar Lee ^b   Winneker, Richard C ^a  

^a WYETH AYERST RESEARCH   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME REGULATION; ESTROGEN ACTIVITY; LIPID BLOOD LEVEL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

EID: 0030962537     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5083     Document Type: Article

References (38)

1. Barret-Connor E, Bush TL 1991 Estrogen and coronary heart disease in women. JAMA 265:1861-1867
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH 1991 Postmcnopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Engl J Med 325:756-762
3. Wagner JD, Clarkson TB, St.Clair RW, Schwenke DC, Shively CA, Adams MR 1991 Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmeno-pausal cynomolgus monkeys. J Clin Invest 88:1995-2002
4. Kushwaha RS, Foster DM, Barrett PHR, Carey KD 1990 Effect of estrogen and progesterone on metabolism of apoprotein B in baboons. Am J Physiol 258:E172-E183
5. Colvin PL, Wagner JD, Heuser MD, Sorci-Thomas MG 1993 Oral contraceptives decrease hepatic cholesterol independent of the LDL receptor in nonhuman primates. Arterioscler Thromb 13:1645-1649
6. Mendelsohn ME, Karas RH 1994 Estrogen and the blood vessel wall. Curr Opin Cardiol 9:619-626
7. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
8. Lafferty FW, Fiske ME 1994 Postmenopausal estrogen replacement: a long-term cohort study. Am J Med 97:66-77
9. Sacks FM, Walsh BW 1990 The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann NY Acad Sci 592:272-285
10. Windler EET, Kovanen PT, Chao Y-S, Brown MS, Havel RJ, Goldstein JL 1980 The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem 255:10464-10471
11. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, Frolik CA, Termine JD, Bryant HU 1994 Raloxifene (LY139481 HCI) prevents bone loss and reduced serum cholesterol without causing uterine hypertrophy. J Clin Invest 93:63-69
12. Washburn SA, Adams MR, Clarkson TB, Adelman SJ 1993 A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat. Am J Obstet Gynecol 169:251-256
13. Kovanen PT, Brown MS, Goldstein JL 1979 Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethinyl estradiol. J Biol Chem 254:11367-11373
14. Chao Y-S, Windier EE, Hen GC, Havel RJ 1979 Hepatic catabolism of rat and human lipoproteins in rats treated with 17α-ethinyl estradiol. J Biol Chem 254:11360-11366
15. Semenkovich CF, Ostlund RE 1987 Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line HepG2. Biochemistry 26:4987-4992
16. Nanjee MN, Koritnik DR, Thomas J, Miller ME 1990 Hormonal determinants of apolipoprotein B, E receptor expression in human liver. Positive association of receptor expression with plasma estrone concentration in middle-aged/elderly women, Biochim Biophys Acta 1046:151-158
17. Ma PTS, Yamamoto T, Goldstein JL, Brown MS 1986 Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17α-ethinyl estradiol. Proc Natl Acad Sci USA 83:792-796
18. Gold E, Stapley S, Goulding A 1994Tamoxifen and norethisterone: effects on plasma cholesterol and total body calcium content in the estrogen-deficient rat. Horm Metab Res 26:100-103
19. Donati RJ, Harper PV, Hughes A, Hay RV 1990 Serum cholesterol- and apolipoprotein B-lowering effects on cis-tamoxifen. Arteriosclerosis 10:822A (Abstract)
20. Evans G, Bryant HU, Magee D, Sato M, Turner RT 1994 The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology 134:2283-2288
21. McDonald CC, Stewart HJ 1991 Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. Br Med J 303:435-437
22. Draper M, Boss SM, Huster WJ, Neild JA 1994 Effects of raloxifene HCl on serum markers of bone and lipid metabolism-dose response relationship. Calcif Tissue Int 4:339 (Abstract)
23. Korenman SG 1969 Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 13:163-177
24. Carroll RJ, Ruppert D 1988 Transformation and Weighting in Regression. Chapman and Hall, New York
25. Bates DM, Watts DG 1988 Nonlinear Regression Analysis: Its Application. Wiley and Sons, New York
26. Jordan VC, Allen KE, Dix CJ 1980 Pharmacology of tamoxifen in laboratory animals. Cancer Treat Rep 64:745-759
27. Hamosh M, Hamosh P 1975 The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. J Clin Invest 55:1132-1135
28. Kim H-J, Kalkhoff RK 1975 Sex steroid influence on triglyceride metabolism. J Clin Invest 56:888-896
29. Tikkanen MJ, Nikkila EA 1987 Regulation of hepatic lipase and serum lipoprotein by sex steroids. Am Heart J 113:562-567
30. Peinado-Onsurbe J, Staels B, Vanderschueren D, Bouillon R, Auwerx J 1993 Effects of sex steroids on hepatic and lipoprotein lipase activity and mRNA in the rat. Horm Res 40:184-188
31. Love RR, Weibe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL 1991 Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 115:860-864
32. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL 1986 Biological effects of transdermal estradiol. N Engl J Med 314:1615-1620
33. Crook D, Cust MP, Gangar KF, Worthington M, Hillard TC, Stevenson JC, Whitehead MI, Wynn V 1992 Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 166:950-955
34. Mattsson L-A, Samsioe G, von Schoultz B, Uvebrant M, Wicklund I 1993 Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: the effects on lipoprotein metabolism in postmentopausal women. Br J Obstet Gynaecol 100:450-453
35. Staels B, Auwerx H, Chan L, van Tol A, Rosseneu M, Verhoeven G 1989 Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine. J Lipid Res 30:1137-1145
36. Yasuda K, Johnston JM 1992 The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat. Endocrinology 130:708-716
37. Eisenfeld AJ, Aten RF 1987 Estrogen receptors and androgen receptors in the mammalian liver. J Steroid Biochem 27:1109-1118
38. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873